TFBS Bioscience (ROCO:6939) Interest Expense : NT$-0.9 Mil (TTM As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. TFBS Bioscience's interest expense for the six months ended in Jun. 2024 was NT$ -0.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-0.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. TFBS Bioscience's Operating Income for the six months ended in Jun. 2024 was NT$ -25.9 Mil. TFBS Bioscience's Interest Expense for the six months ended in Jun. 2024 was NT$ -0.6 Mil. TFBS Bioscience did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TFBS Bioscience Interest Expense Historical Data

The historical data trend for TFBS Bioscience's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience Interest Expense Chart

TFBS Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.36

-0.31

-0.65

-0.60

TFBS Bioscience Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial			-0.26	-0.39	-0.32	-0.28	-0.60

TFBS Bioscience Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.9 Mil.

TFBS Bioscience (ROCO:6939) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

TFBS Bioscience's Interest Expense for the six months ended in Jun. 2024 was NT$-0.6 Mil. Its Operating Income for the six months ended in Jun. 2024 was NT$-25.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was NT$87.4 Mil.

TFBS Bioscience's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

TFBS Bioscience did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

TFBS Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN

Website

https://www.tfbsbio.com

TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines